 |
 |
| A novel VTA for the treatment of solid tumours. Phase III trial in mesothelioma ongoing in Europe and US. Randomised Phase II trials ongoing in non-small-cell lung cancer, ovarian cancer, soft tissue sarcomas and mesothelioma as maintenance treatment. Completed Phase II trials in colorectal cancer, liver cancer and small-cell lung cancer. |
 |
|
 |
 |
| Cell-based therapy enabling safe haploidentical haematopoietic stem cell transplantation (HSCT) for the treatment of haematological malignancies. Phase III ongoing in Europe for high-risk leukaemia. |
 |
|
 |
|
|
